SK
Sushil Khanna
About Sushil Khanna
Data last updated:
Sushil Khanna is a Director at Sika Interplant Systems Limited (since 2024). The companies operate in Machinery and Equipment, Healthcare and Pharma. Sika Interplant Systems Limited reported revenue of ₹216 Cr (FY 2026). Earlier, Sushil Khanna was a Nominee Director at Glaxosmithkline Asia Private Limited (2007–2012) and Director at Gsk Pharma India Private Limited (2009–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Sep 2024 | 1985 | ₹216 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 01 Apr 2007 | 1995 | ₹2,362 Cr (FY 2023) | Active | |
| Director | 01 Sep 2009 | 2000 | ₹31.87 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sushil Khanna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anuradha Sikka | 00902914 | Sika Interplant Systems Limited | Director |
| Garimella Bhaskar Venkata Satya | 08181557 | Sika Interplant Systems Limited | Director |
| Kendaganna Swamy Sathish | Sika Interplant Systems Limited | Cfo | |
| Kunal Sikka | Sika Interplant Systems Limited | Ceo | |
| Kunal Sikka | 05240807 | Sika Interplant Systems Limited | Managing Director |
| Parasuramachetty Jayapal | 10589149 | Sika Interplant Systems Limited | Director |
| Rajeev Sikka | 00902887 | Sika Interplant Systems Limited | Whole-Time Director |
| Suraj Kumar Sahu | Sika Interplant Systems Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Khanna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Khanna
Sushil Khanna currently holds 1 directorship: Sika Interplant Systems Limited (Director, since 20 Sep 2024, revenue ₹216 Cr (FY 2026)).
Sushil Khanna was first appointed on 01 Apr 2007 as Nominee Director at Glaxosmithkline Asia Private Limited. The most recent appointment on record is 20 Sep 2024 at Sika Interplant Systems Limited.
Sushil Khanna held 2 earlier board appointments: Glaxosmithkline Asia Private Limited (Nominee Director, 01 Apr 2007 to 27 Mar 2012); Gsk Pharma India Private Limited (Director, 01 Sep 2009 to 30 Nov 2016).
The current boards of Sushil Khanna's companies include Anuradha Sikka (Sika Interplant Systems Limited), Garimella Bhaskar Venkata Satya (Sika Interplant Systems Limited), Kendaganna Swamy Sathish (Sika Interplant Systems Limited), Kunal Sikka (Sika Interplant Systems Limited), Kunal Sikka (Sika Interplant Systems Limited), Parasuramachetty Jayapal (Sika Interplant Systems Limited), among others.